Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention

Nicky Lewis; Barry Eggleston; Redonna K. Chandler; Dawn Goddard-Eckrich; Jamie E. Luster; Dacia D. Beard; Emma Rodgers; Rouba Chahine; Philip M. Westgate; Shoshana N. Benjamin; Ja Nae Holloway; Thomas Clarke; R. Craig Lefebvre; Michael D. Stein; Donald W. Helme; Jennifer Reynolds; Sharon L. Walsh; Darcy Freedman; Nabila El-Bassel; Kara Stephens; Anita Silwal; Michelle Lofwall; Janet E. Childerhose; Hilary L. Surratt; Brooke N. Crockett; Amy L. Farmer; James L. David; Laura Fanucchi; Judy Harness; Ben Wilburn; Kelli Bursey; Kristin Mattson; Sarah Mann; Rebecca D. Jackson; Aimee Shadwick; Katherine Calver; Deborah Chassler; Jennifer Kimball; Nancy Regan; Jeffrey H. Samet; Rachel Sword-Cruz; Michael D. Slater

doi:10.1371/journal.pone.0308965

Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention

Nicky Lewis, Barry Eggleston, Redonna K. Chandler, Dawn Goddard-Eckrich, Jamie E. Luster, Dacia D. Beard, Emma Rodgers, Rouba Chahine, Philip M. Westgate, Shoshana N. Benjamin, Ja Nae Holloway, Thomas Clarke, R. Craig Lefebvre, Michael D. Stein, Donald W. Helme, Jennifer Reynolds, Sharon L. Walsh, Darcy Freedman, Nabila El-Bassel, Kara StephensAnita Silwal, Michelle Lofwall, Janet E. Childerhose, Hilary L. Surratt, Brooke N. Crockett, Amy L. Farmer, James L. David, Laura Fanucchi, Judy Harness, Ben Wilburn, Kelli Bursey, Kristin Mattson, Sarah Mann, Rebecca D. Jackson, Aimee Shadwick, Katherine Calver, Deborah Chassler, Jennifer Kimball, Nancy Regan, Jeffrey H. Samet, Rachel Sword-Cruz, Michael D. Slater

Research output: Contribution to journal › Article › peer-review

Abstract

Background The HEALing Communities Study (HCS) included health campaigns as part of a community-engaged intervention to reduce opioid-related overdose deaths in 67 highly impacted communities across Kentucky, Massachusetts, New York, and Ohio. Five campaigns were developed with community input to provide information on opioid use disorder (OUD) and overdose prevention, reduce stigma, and build demand for evidence-based practices (EBPs). An evaluation examined the recognition of campaign messages about naloxone and whether stigma and efficacy beliefs regarding OUD treatment and naloxone changed in HCS intervention communities. Methods Data were collected through surveys offered on Facebook/Instagram to members of communities participating in the HCS intervention and wait-list control communities. Results Participants in HCS intervention communities reported a reduction in stigma regarding OUD and increased efficacy beliefs regarding naloxone associated with recognition of campaign messages. However, this finding is cautiously interpreted as there was no clear evidence for recognition differences between the treatment/control conditions. Conclusion Study findings indicate associations between campaign message recognition and positive outcomes. Results also highlight possible challenges concerning evaluations of social media campaigns using conventional evaluation techniques.

Original language	English
Article number	e0308965
Journal	PLoS ONE
Volume	19
Issue number	12
DOIs	https://doi.org/10.1371/journal.pone.0308965
State	Published - Dec 2024

Access to Document

10.1371/journal.pone.0308965

Cite this

Lewis, N., Eggleston, B., Chandler, R. K., Goddard-Eckrich, D., Luster, J. E., Beard, D. D., Rodgers, E., Chahine, R., Westgate, P. M., Benjamin, S. N., Holloway, J. N., Clarke, T., Lefebvre, R. C., Stein, M. D., Helme, D. W., Reynolds, J., Walsh, S. L., Freedman, D., El-Bassel, N., ... Slater, M. D. (2024). Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention. PLoS ONE, 19(12), Article e0308965. https://doi.org/10.1371/journal.pone.0308965

@article{b718fa6c948d469fbe655206cea010fb,

title = "Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention",

abstract = "Background The HEALing Communities Study (HCS) included health campaigns as part of a community-engaged intervention to reduce opioid-related overdose deaths in 67 highly impacted communities across Kentucky, Massachusetts, New York, and Ohio. Five campaigns were developed with community input to provide information on opioid use disorder (OUD) and overdose prevention, reduce stigma, and build demand for evidence-based practices (EBPs). An evaluation examined the recognition of campaign messages about naloxone and whether stigma and efficacy beliefs regarding OUD treatment and naloxone changed in HCS intervention communities. Methods Data were collected through surveys offered on Facebook/Instagram to members of communities participating in the HCS intervention and wait-list control communities. Results Participants in HCS intervention communities reported a reduction in stigma regarding OUD and increased efficacy beliefs regarding naloxone associated with recognition of campaign messages. However, this finding is cautiously interpreted as there was no clear evidence for recognition differences between the treatment/control conditions. Conclusion Study findings indicate associations between campaign message recognition and positive outcomes. Results also highlight possible challenges concerning evaluations of social media campaigns using conventional evaluation techniques.",

author = "Nicky Lewis and Barry Eggleston and Chandler, {Redonna K.} and Dawn Goddard-Eckrich and Luster, {Jamie E.} and Beard, {Dacia D.} and Emma Rodgers and Rouba Chahine and Westgate, {Philip M.} and Benjamin, {Shoshana N.} and Holloway, {Ja Nae} and Thomas Clarke and Lefebvre, {R. Craig} and Stein, {Michael D.} and Helme, {Donald W.} and Jennifer Reynolds and Walsh, {Sharon L.} and Darcy Freedman and Nabila El-Bassel and Kara Stephens and Anita Silwal and Michelle Lofwall and Childerhose, {Janet E.} and Surratt, {Hilary L.} and Crockett, {Brooke N.} and Farmer, {Amy L.} and David, {James L.} and Laura Fanucchi and Judy Harness and Ben Wilburn and Kelli Bursey and Kristin Mattson and Sarah Mann and Jackson, {Rebecca D.} and Aimee Shadwick and Katherine Calver and Deborah Chassler and Jennifer Kimball and Nancy Regan and Samet, {Jeffrey H.} and Rachel Sword-Cruz and Slater, {Michael D.}",

note = "Publisher Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.",

year = "2024",

month = dec,

doi = "10.1371/journal.pone.0308965",

language = "English",

volume = "19",

journal = "PLoS ONE",

issn = "1932-6203",

number = "12",

}

Lewis, N, Eggleston, B, Chandler, RK, Goddard-Eckrich, D, Luster, JE, Beard, DD, Rodgers, E, Chahine, R, Westgate, PM, Benjamin, SN, Holloway, JN, Clarke, T, Lefebvre, RC, Stein, MD, Helme, DW, Reynolds, J, Walsh, SL, Freedman, D, El-Bassel, N, Stephens, K, Silwal, A, Lofwall, M, Childerhose, JE, Surratt, HL, Crockett, BN, Farmer, AL, David, JL, Fanucchi, L, Harness, J, Wilburn, B, Bursey, K, Mattson, K, Mann, S, Jackson, RD, Shadwick, A, Calver, K, Chassler, D, Kimball, J, Regan, N, Samet, JH, Sword-Cruz, R & Slater, MD 2024, 'Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention', PLoS ONE, vol. 19, no. 12, e0308965. https://doi.org/10.1371/journal.pone.0308965

TY - JOUR

T1 - Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention

AU - Lewis, Nicky

AU - Eggleston, Barry

AU - Chandler, Redonna K.

AU - Goddard-Eckrich, Dawn

AU - Luster, Jamie E.

AU - Beard, Dacia D.

AU - Rodgers, Emma

AU - Chahine, Rouba

AU - Westgate, Philip M.

AU - Benjamin, Shoshana N.

AU - Holloway, Ja Nae

AU - Clarke, Thomas

AU - Lefebvre, R. Craig

AU - Stein, Michael D.

AU - Helme, Donald W.

AU - Reynolds, Jennifer

AU - Walsh, Sharon L.

AU - Freedman, Darcy

AU - El-Bassel, Nabila

AU - Stephens, Kara

AU - Silwal, Anita

AU - Lofwall, Michelle

AU - Childerhose, Janet E.

AU - Surratt, Hilary L.

AU - Crockett, Brooke N.

AU - Farmer, Amy L.

AU - David, James L.

AU - Fanucchi, Laura

AU - Harness, Judy

AU - Wilburn, Ben

AU - Bursey, Kelli

AU - Mattson, Kristin

AU - Mann, Sarah

AU - Jackson, Rebecca D.

AU - Shadwick, Aimee

AU - Calver, Katherine

AU - Chassler, Deborah

AU - Kimball, Jennifer

AU - Regan, Nancy

AU - Samet, Jeffrey H.

AU - Sword-Cruz, Rachel

AU - Slater, Michael D.

N1 - Publisher Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

PY - 2024/12

Y1 - 2024/12

N2 - Background The HEALing Communities Study (HCS) included health campaigns as part of a community-engaged intervention to reduce opioid-related overdose deaths in 67 highly impacted communities across Kentucky, Massachusetts, New York, and Ohio. Five campaigns were developed with community input to provide information on opioid use disorder (OUD) and overdose prevention, reduce stigma, and build demand for evidence-based practices (EBPs). An evaluation examined the recognition of campaign messages about naloxone and whether stigma and efficacy beliefs regarding OUD treatment and naloxone changed in HCS intervention communities. Methods Data were collected through surveys offered on Facebook/Instagram to members of communities participating in the HCS intervention and wait-list control communities. Results Participants in HCS intervention communities reported a reduction in stigma regarding OUD and increased efficacy beliefs regarding naloxone associated with recognition of campaign messages. However, this finding is cautiously interpreted as there was no clear evidence for recognition differences between the treatment/control conditions. Conclusion Study findings indicate associations between campaign message recognition and positive outcomes. Results also highlight possible challenges concerning evaluations of social media campaigns using conventional evaluation techniques.

AB - Background The HEALing Communities Study (HCS) included health campaigns as part of a community-engaged intervention to reduce opioid-related overdose deaths in 67 highly impacted communities across Kentucky, Massachusetts, New York, and Ohio. Five campaigns were developed with community input to provide information on opioid use disorder (OUD) and overdose prevention, reduce stigma, and build demand for evidence-based practices (EBPs). An evaluation examined the recognition of campaign messages about naloxone and whether stigma and efficacy beliefs regarding OUD treatment and naloxone changed in HCS intervention communities. Methods Data were collected through surveys offered on Facebook/Instagram to members of communities participating in the HCS intervention and wait-list control communities. Results Participants in HCS intervention communities reported a reduction in stigma regarding OUD and increased efficacy beliefs regarding naloxone associated with recognition of campaign messages. However, this finding is cautiously interpreted as there was no clear evidence for recognition differences between the treatment/control conditions. Conclusion Study findings indicate associations between campaign message recognition and positive outcomes. Results also highlight possible challenges concerning evaluations of social media campaigns using conventional evaluation techniques.

UR - http://www.scopus.com/inward/record.url?scp=85211025742&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0308965

DO - 10.1371/journal.pone.0308965

M3 - Article

C2 - 39630633

AN - SCOPUS:85211025742

SN - 1932-6203

VL - 19

JO - PLoS ONE

JF - PLoS ONE

IS - 12

M1 - e0308965

ER -

Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention

Abstract

Access to Document

Other files and links

Fingerprint

Cite this